ICANS - Institut de cancérologie Strasbourg Europe

Strasbourg 67000

1 studies enrolling now · 2 studies all time

What they study most

Fallopian Tube Cancer, Metastatic HER2-positive Breast Cancer, Ovarian Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Carcinoma

Studies at this site

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer — Completed